Latest News

Feedback surges as Bleepa selected for DigitalHealth London accelerator programme


Feedback PLC (LON:FDBK) shares were higher on Tuesday as the company said its Bleepa clinical messaging app has been selected for DigitalHealth London’s 2020 12-month accelerator programme to promote innovative technologies to London National Health Service (NHS) hospitals.

The AIM-listed firm said the accelerator aims to speed up the adoption of technology within London’s NHS, relieving high pressure on services and empowering patients to manage their health.

READ: Feedback focuses on creating a strong platform for revenue growth

The accelerator works with up to 20 high potential small and medium enterprises (SMEs) over the 12 month period to offer bespoke support and advice, a programme of expert-led workshops and events, and broker meaningful connections between innovators and NHS organisations with specific challenges. Each SME is also assigned an NHS Navigator, an experienced professional from the NHS with the expertise to share advice on products in development, NHS navigation and business models.

“DigitalHealth.London is a targeted accelerator for London hospitals with a focus to scan the horizon for the very best of new innovative healthcare technologies, which it then showcases to London-based hospitals.  It has an extremely rigorous selection process and we are delighted that Bleepa has been chosen as part of the 2020 offering”, Feedback chief executive Tom Oakley said in a statement.

“For us, this is an important opportunity to really get in front of the London hospital network to show them what Bleepa can do, how it can revolutionise their imaging communications and ultimately, why they should choose Bleepa”, he added.

Feedback shares jumped 13% to 1.3p in mid-morning trading.

Tavistock Investments grows profits as cost-saving initiatives bear fruit

Previous article

City Pub Group appoints Toby Smith to its board in the newly created role of chief operating officer

Next article

You may also like


Leave a reply

Your email address will not be published.

More in Latest News